Clinical use of monoclonal antibody HuJ591 therapy: Targeting prostate specific membrane antigen Review uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Prostatic Neoplasms

abstract

  • Early results of clinical studies indicate that mAb HuJ591 represents targeted therapy to PSMA and has therapeutic potential in prostate cancer and other urological and solid tumor malignancies.

publication date

  • December 2003

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.ju.0000095151.97404.7c

PubMed ID

  • 14610416

Additional Document Info

start page

  • S84

end page

  • 8; discussion S88-9

volume

  • 170

number

  • 6 II